HBLYX | JIAGX | HBLYX / JIAGX | |
Total Expense Ratio | 0.67 | 1.69 | 40% |
Annual Report Gross Expense Ratio | 0.67 | 1.81 | 37% |
Fund Existence | 19 years | 11 years | - |
Gain YTD | 9.048 | 8.863 | 102% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 1000 | 25,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 11.8B | 112M | 10,536% |
Annual Yield % from dividends | 3.44 | 4.59 | 75% |
Returns for 1 year | 2.51 | 7.57 | 33% |
Returns for 3 years | 25.18 | 34.46 | 73% |
Returns for 5 years | 17.35 | 18.33 | 95% |
Returns for 10 years | 48.84 | 37.52 | 130% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETIHX | 43.18 | 0.06 | +0.14% |
Eventide Healthcare & Life Sciences I | |||
FGRCX | 28.71 | N/A | N/A |
Fidelity Advisor Mega Cap Stock C | |||
MSBVX | 11.48 | N/A | N/A |
Morgan Stanley American Resilience I | |||
IJPIX | 12.74 | -0.01 | -0.08% |
VY® JPMorgan Emerging Markets Equity S | |||
AIOCX | 10.29 | -0.05 | -0.48% |
American Century International Opps C |